Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax May Extend Its 2,000% Gain

TheMotleyFool

0 0

Novavax (NASDAQ: NVAX) surged more than 2,000% last year for the best stock performance -- all industries included. Though it's unlikely to repeat such an increase, there still is plenty of room for share growth. In this Motley Fool Live video recorded on Jan. 22, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the catalysts ahead for Novavax (NASDAQ: NVAX), which soon will report phase 3 data for its coronavirus vaccine candidate.

Source Fool.com

Like: 0

NVAX

Share